pentagastrin has been researched along with MEA 2b in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biarnés, J; Gómez, JM; Martí, T; Volpini, V | 1 |
Bastie, D; Caron, P; Chabre, O; Chabrier, G; Conte-Devolx, B; Henry, JF; Lecomte, P; Maes, B; Nguyen, L; Niccoli-Sire, P; Rohmer, V | 1 |
Barontini, M; de, M; Domene, HM; Elsner, B; Garcia, R; Iorcansky, S; Perinetti, H; Pusiol, E; Ring, A; Roque, M; Sanso, GE | 1 |
3 other study(ies) available for pentagastrin and MEA 2b
Article | Year |
---|---|
Neuromas and prominent corneal nerves without MEN 2B.
Topics: Adolescent; Adult; Calcitonin; Calcium; Catecholamines; Cornea; Diagnosis, Differential; DNA Mutational Analysis; Female; Humans; Mucous Membrane; Multiple Endocrine Neoplasia Type 2b; Neuroma; Pentagastrin; Phosphates; Proto-Oncogene Mas; Tongue Neoplasms | 1998 |
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Calcitonin; Carcinoma, Medullary; Catecholamines; Child; Child, Preschool; Drosophila Proteins; Humans; Infant; Magnetic Resonance Imaging; Metanephrine; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Mutation; Pentagastrin; Pheochromocytoma; Prospective Studies; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms; Tomography, X-Ray Computed | 2001 |
Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Medullary; Catecholamines; Child; Child, Preschool; DNA Mutational Analysis; DNA Primers; DNA, Neoplasm; Drosophila Proteins; Female; Germ-Line Mutation; Humans; Hyperplasia; Infant; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Omeprazole; Pentagastrin; Polymerase Chain Reaction; Prognosis; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy | 2002 |